本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ovid Therapeutics Inc.

0.3236
+0.00842.66%
盘后0.33260.0090+2.78%19:31 EDT
成交量:24.64万
成交额:7.98万
市值:2,299.99万
市盈率:-0.87
高:0.3295
开:0.3235
低:0.3145
收:0.3152
数据加载中...
2020/05/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/03/30

重要事件披露

Current report, items 8.01 and 9.01
2020/03/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/13

重要事件披露

Current report, items 7.01 and 9.01
2020/03/11

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/11

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/02

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

重要事件披露

Current report, items 8.01 and 9.01
2019/12/24

重要事件披露

Current report, item 5.02
2019/11/27

超过5%披露

[Amend] General statement of acquisition of beneficial ownership